[1]
|
Norman, J.K., Parke, J.T., Wilson, D.A. and McNall-Knapp, R.Y. (2007) Reversible Posterior Leukoencephalopathy Syndrome in Children Undergoing Induction Therapy for Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer, 49, 198-203. https://doi.org/10.1002/pbc.20597
|
[2]
|
Gupta, A., Swaroop, C., Rastogi, R., Garg, R. and Bakhshi, S. (2008) Simultaneous Occurrence of Posterior Reversible Leukoencephalopathy Syndrome in Two Cases of Childhood Acute Lymphoblastic Leukemia Induction Chemotherapy. Pediatric Hematology and Oncology, 25, 351-358. https://doi.org/10.1080/08880010802016052
|
[3]
|
Morris, E.B., Laningham, F.H., Sandlund, J.T. and Khan, R.B. (2007) Posterior Reversible Encephalopathy Syndrome in Children with Cancer. Pediatric Blood & Cancer, 48, 152-159. https://doi.org/10.1002/pbc.20703
|
[4]
|
Siebert, E., Bohner, G., Liebig, T., Endres, M. and Liman, T.G. (2017) Factors Associated with Fatal Outcome in Posterior Reversible Encephalopathy Syndrome: A Retrospective Analysis of the Berlin PRES Study. Journal of Neurology, 264, 237-242. https://doi.org/10.1007/s00415-016-8328-4
|
[5]
|
Hinchey, J., Chaves, C., Appignani, B., Breen, J., Pao, L., Wang, A., Pessin, M.S., Lamy, C., Mas, J.L. and Caplan, L.R. (1996) A Reversible Posterior Leukoencephalopathy Syndrome. The New England Journal of Medicine, 334, 494-500.
https://doi.org/10.1056/NEJM199602223340803
|
[6]
|
Millichap, J.G. (2015) Posterior Reversible Encephalopathy Syndrome in ALL. Pediatric Neurology Briefs, 29, Article 56.
|
[7]
|
Kanekiyo, T., Hara, J., Matsuda-Hashii, Y., Fujisaki, H., Tokimasa, S., Sawada, A., Kubota, K., Shimono, K., Imai, K. and Ozono, K. (2005) Tacrolimus-Related Encephalo-pathy following Allogeneic Stem Cell Transplantation in Children. International Journal of Hematology, 81, 264-268. https://doi.org/10.1532/IJH97.04162
|
[8]
|
Kim, S.J., Im, S.A., Lee, J.W., Chung, N.G., Cho, B., Kim, H.K. and Lee, I.G. (2012) Predisposing Factors of Posterior Reversible Encephalopathy Syndrome in Acute Childhood Leukemia. Pediatric Neurology, 47, 436-442.
https://doi.org/10.1016/j.pediatrneurol.2012.07.011
|
[9]
|
Panis, B., Vlaar, A.M., van Well, G.T., Granzen, B., We-ber, J.W., Postma, A.A. and Klinkenberg, S. (2010) Posterior Reversible Encephalopathy Syndrome in Paediatric Leu-kaemia. European Journal of Pediatric Neurology, 14, 539-545.
https://doi.org/10.1016/j.ejpn.2010.01.003
|
[10]
|
Bartynski, W.S., Tan, H.P., Boardman, J.F., Shapiro, R. and Marsh, J.W. (2008) Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation. American Journal of Neuroradiology, 29, 924-930.
https://doi.org/10.3174/ajnr.A0960
|
[11]
|
Bartynski, W.S., Zeigler, Z., Spearman, M.P., Lin, L., Shadduck, R.K. and Lister, J. (2001) Etiology of Cortical and White Matter Lesions in Cyclosporin-A and FK-506 Neurotoxicity. American Journal of Neuroradiology, 22, 1901-1914.
|
[12]
|
Reinohs, M., Straube, T., Baum, P., Berrouschot, J. and Wagner, A. (2002) Recurrent Reversible Cerebral Edema after Long Term Immunosuppression with Tacrolimus. Journal of Neurol-ogy, 249, 780-781.
https://doi.org/10.1007/s00415-002-0703-7
|
[13]
|
Tetsuka, S. and Ogawa, T. (2019) Posterior Reversible Encepha-lopathy Syndrome: A Review with Emphasis on Neuroimaging Characteristics. Journal of the Neurological Sciences, 404, 72-79. https://doi.org/10.1016/j.jns.2019.07.018
|
[14]
|
Chan, J.D. (1998) Pharmacokinetic Drug Interactions of Vinca Alkaloids: Summary of Case Reports. Pharmacotherapy, 18, 1304-1307.
|
[15]
|
Li, Y., Theuretzbacher, U., Clancy, C.J., Nguyen, M.H. and Derendorf, H. (2010) Pharmacokinetic/Pharmacodynamic Profile of Posaconazole. Clinical Pharmacokinetics, 49, 379-396. https://doi.org/10.2165/11319340-000000000-00000
|
[16]
|
Chen, L., Krekels, E.H.J., Verweij, P.E., Buil, J.B., Knibbe, C.A.J. and Brüggemann, R.J.M. (2020) Pharmacokinetics and Pharmacody-namics of Posaconazole. Drugs, 80, 671-695. https://doi.org/10.1007/s40265-020-01306-y
|
[17]
|
Khalil, H.A., ElKhatib, M.A.W., Belal, T.S., El-Yazbi, A.F. and Hamdy, D.A. (2017) Hyperlipidemia Alters the Pharmacokinetics of Posaconazole and Vincristine upon Co-Administration in Rats. Drugs in R & D, 17, 287-296.
https://doi.org/10.1007/s40268-017-0178-8
|
[18]
|
Gao, B., Lyu, C., Lerner, A. and McKinney, A.M. (2018) Con-troversy of Posterior Reversible Encephalopathy Syndrome: What Have We Learnt in the Last 20 Years? Journal of Neurology, Neurosurgery, and Psychiatry, 89, 14-20.
https://doi.org/10.1136/jnnp-2017-316225
|
[19]
|
Fugate, J.E. and Rabinstein, A.A. (2015) Posterior Reversible En-cephalopathy Syndrome: Clinical and Radiological Manifestations, Pathophysiology, and Outstanding Questions. The Lancet Neurology, 14, 914-925.
https://doi.org/10.1016/S1474-4422(15)00111-8
|
[20]
|
Liman, T.G., Siebert, E. and Endres, M. (2019) Posterior Reversible Encephalopathy Syndrome. Current Opinion in Neurology, 32, 25-35. https://doi.org/10.1097/WCO.0000000000000640
|
[21]
|
Fischer, M. and Schmutzhard, E. (2017) Posterior Reversi-ble Encephalopathy Syndrome. Journal of Neurology, 264, 1608-1616. https://doi.org/10.1007/s00415-016-8377-8
|
[22]
|
Singer, S., Grommes, C., Reiner, A.S., Rosenblum, M.K. and DeAngelis, L.M. (2015) Posterior Reversible Encephalopathy Syndrome in Patients with Cancer. The Oncologist, 20, 806-811.
https://doi.org/10.1634/theoncologist.2014-0149
|
[23]
|
Chen, Z., Shen, G.Q., Lerner, A. and Gao, B. (2017) Im-mune System Activation in the Pathogenesis of Posterior Reversible Encephalopathy Syndrome. Brain Research Bulletin, 131, 93-99.
https://doi.org/10.1016/j.brainresbull.2017.03.012
|
[24]
|
Bartynski, W.S. and Boardman, J.F. (2008) Catheter Angi-ography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy Syndrome. American Journal of Neuroradiology, 29, 447-455.
https://doi.org/10.3174/ajnr.A0839
|
[25]
|
Datar, S., Singh, T.D., Fugate, J.E., Mandrekar, J., Rabinstein, A.A. and Hocker, S. (2015) Albuminocytologic Dissociation in Posterior Reversible Encephalopathy Syndrome. Mayo Clinic Proceedings, 90, 1366-1371.
https://doi.org/10.1016/j.mayocp.2015.07.018
|
[26]
|
Neeb, L., Hoekstra, J., Endres, M., Siegerink, B., Siebert, E. and Liman, T.G. (2016) Spectrum of Cerebral Spinal Fluid Findings in Patients with Posterior Reversible Encephalopa-thy Syndrome. Journal of Neurology, 263, 30-34.
https://doi.org/10.1007/s00415-015-7928-8
|
[27]
|
Ellis, C.A., McClelland, A.C., Mohan, S., Kuo, E., Kasner, S.E., Zhang, C., Khankhanian, P. and Balu, R. (2019) Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome: Implications of Elevated Protein and Pleocytosis. The Neurohospitalist, 9, 58-64. https://doi.org/10.1177/1941874418802061
|
[28]
|
Liman, T.G., Bohner, G., Endres, M. and Siebert, E. (2014) Dis-charge Status and in-Hospital Mortality in Posterior Reversible Encephalopathy Syndrome. Acta Neurologica Scandina-vica, 130, 34-39. https://doi.org/10.1111/ane.12213
|